ConductScience.org, home

Paper39713637

Systematic Analysis of Disulfidptosis-Related lncRNAs in Hepatocellular Carcinoma with Vascular Invasion Revealed That AC131009.1 Can Promote HCC Invasion and Metastasis through Epithelial-Mesenchymal Transition.

Gu X and 5 others. ACS Omega, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Systematic Analysis of Disulfidptosis-Related lncRNAs in Hepatocellular Carcinoma with Vascular Invasion Revealed That AC131009.1 Can Promote HCC Invasion and Metastasis through Epithelial-Mesenchymal Transition. Papers, record 39713637. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39713637

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Systematic Analysis of Disulfidptosis-Related lncRNAs in Hepatocellular Carcinoma with Vascular Invasion Revealed That AC131009.1 Can Promote HCC Invasion and Metastasis through Epithelial-Mesenchymal Transition.
PubMed
Journal
ACS Omega
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.73, provisional
iCite
Revised in PubMed
2025-01-04
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130692831Prognosticators of hepatocellular carcinoma with intrahepatic vascular invasion.Tzu Chi Med J2019https://conductscience.org/library/papers/30692831PubMed
224254204The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.Ann Surg Oncol2014https://conductscience.org/library/papers/24254204PubMed
333538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
434722325Neutrophils and Lymphocytes Can Help Distinguish Asymptomatic COVID-19 From Moderate COVID-19.Front Cell Infect Microbiol2021https://conductscience.org/library/papers/34722325PubMed
536147735Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma.Front Cell Dev Biol2022https://conductscience.org/library/papers/36147735PubMed
630788629Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma.Ann Surg Oncol2019https://conductscience.org/library/papers/30788629PubMed
736747082Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis.Nat Cell Biol2023https://conductscience.org/library/papers/36747082PubMed
832659252Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy.Biochim Biophys Acta Rev Cancer2020https://conductscience.org/library/papers/32659252PubMed
937101248Disulfidptosis: a new target for metabolic cancer therapy.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/37101248PubMed
1025736707Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs.Exp Anim2015https://conductscience.org/library/papers/25736707PubMed
1136596869Long non-coding RNAs: definitions, functions, challenges and recommendations.Nat Rev Mol Cell Biol2023https://conductscience.org/library/papers/36596869PubMed
1232782275Targeted therapy for hepatocellular carcinoma.Signal Transduct Target Ther2020https://conductscience.org/library/papers/32782275PubMed
1330967904Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation.World J Hepatol2019https://conductscience.org/library/papers/30967904PubMed
1436873490An angiogenesis-related three-long non-coding ribonucleic acid signature predicts the immune landscape and prognosis in hepatocellular carcinoma.Heliyon2023https://conductscience.org/library/papers/36873490PubMed
1529212306Oncogene-Driven Metabolic Alterations in Cancer.Biomol Ther (Seoul)2018https://conductscience.org/library/papers/29212306PubMed
1635020204Cancer statistics, 2022.CA Cancer J Clin2022https://conductscience.org/library/papers/35020204PubMed
1730416681LncRNAs as novel players in hepatocellular carcinoma recurrence.Oncotarget2018https://conductscience.org/library/papers/30416681PubMed
1834838596Alternative animal models in predictive toxicology.Toxicology2022https://conductscience.org/library/papers/34838596PubMed
1934260682oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data.Brief Bioinform2021https://conductscience.org/library/papers/34260682PubMed
2037550755Novel risk model based on angiogenesis-related lncRNAs for prognosis prediction of hepatocellular carcinoma.Cancer Cell Int2023https://conductscience.org/library/papers/37550755PubMed

See all 50 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42711333Disulfidptosis: molecular mechanisms and therapeutic targets.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42711333PubMed
42177709Disulfidptosis in hepatocellular carcinoma: molecular mechanisms, therapeutic potential, and exploratory insights into chronic liver diseases.Apoptosis2026https://conductscience.org/library/papers/42177709PubMed
40790550Elucidating the role of AC026412.3 in hepatocellular carcinoma: a prognostic disulfidptosis-related LncRNAs model perspective.BMC Gastroenterol2025https://conductscience.org/library/papers/40790550PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
LUCAT1100505994PubTator's text mininghttps://conductscience.org/library/genes/100505994

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39713637

GET https://conductscience.org/api/papers/v1/39713637/references?page=2